Stock fact sheet · data as of
PRF Technologies Ltd. (PRFX): fair value, margin of safety and Wheel Score
Ticker symbol PRFX · Healthcare · Drug Manufacturers - Specialty & Generic · Israel · Speculative
Is PRFX undervalued?
At 0.7650 (close of 5 Nov 2026), PRFX trades 88% below the GLS average fair value of 6.39. That average comes from 1 models run on the latest filings, and 1 of them land above the current price. Margins of safety over 30% are the exception rather than the rule across the ~7,400 stocks we value each night, so the number earns PRF Technologies Ltd. the full Value points in the Wheel Score - and a closer look at what the market is pricing in.
Only 1 of the nine models produced a value (DCF); the others need a dividend, positive free cash flow or positive book value the company does not have yet, so the average rests on a narrow base.
The nightly engine files PRFX under Speculative - it is losing money or its Piotroski health score is 3 or lower - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.
Nine valuation models for PRFX
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | 6.39 | +735% | Present value of the projected free cash flows, discounted at the cost of capital |
| Graham Number | - | - | The most a defensive investor pays for the earnings and book value per share; no value tonight |
| Graham Growth | - | - | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields; no value tonight |
| Lynch | - | - | EPS × the earnings growth rate (PEG of 1), growth capped at 25%; no value tonight |
| GLS Growth | - | - | EPS compounded ten years at the blended growth rate, discounted back at 15% a year; no value tonight |
| 10 Cap | - | - | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%; no value tonight |
| Payback Time | - | - | Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight |
| DDM | - | - | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight |
| EPV | - | - | Earnings power value: current EPS capitalised at 9% with no growth; no value tonight |
| Zombie (liquidation) | 20.40 | +2567% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 0.0000 | -100% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
Financial health is weak: PRFX passes 3 of the nine Piotroski tests. Our scans drop the stock at the health filter; a low score is often the reason a stock looks cheap on the valuation models. The GLS Moat score is low at 1.4 out of 10: returns on capital, margins or the balance sheet have not shown a lasting edge yet - often a young company, a thin-margin business or one that has only recently turned profitable.
Returns on capital are thin or negative - ROIC -56.5%, ROE -56.6%, ROA -40.3% - with debt at 0.00 times equity and negative free cash flow.
PRF Technologies Ltd. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain.
Institutional ownership scores 4/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.
| Piotroski F-score | 3 / 9 | ROIC | -56.5% |
|---|---|---|---|
| GLS Moat | 1.4 / 10 | ROE | -56.6% |
| Debt / equity | 0.00 | ROA | -40.3% |
| Free-cash-flow yield | -11980.0% | Payout ratio | 0% |
| Institutions | 4 / 10 | Insiders · Congress | 5 · 5 / 10 |
Wheel Score 25: No options
PRFX has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business. It fails the first Wheel Trade Filter (options that actually trade), so the score stays under 70 and is shown as "No options" (25 here). The valuation and quality numbers still apply to owning the shares outright.
Volume runs at 448k shares a day on a market cap of $62K, with a beta of 1.13; the Stability part of the Wheel Score rates that fair.
| Filter | Wheel Trade Filter | Result | Detail |
|---|---|---|---|
| 1 | Options that actually trade | Fails | no listed options |
| 2 | A real business, not a gamble | Fails | speculative (a loss, or a weak Piotroski score) |
| 3 | Below fair value | Passes | Trading below the nine-model average fair value (margin of safety above 0) |
| 4 | Financially healthy | Fails | Piotroski 3/9 (under 6) |
| 5 | Can repay its debt | Passes | Long-term debt repaid from 3 years of operating cash flow or less (6 for real estate and utilities; banks and insurers are not judged on it) |
| 6 | No serious red flags | Passes | Red Flags score 60 or more out of 100 (earnings, margins, debt, analysts, filings and price checked the same way for every stock) |
| 7 | A premium worth selling | Fails | no implied volatility |
| 8 | Big enough | Fails | market cap $0M (under $1.0B) |
| 9 | Not a penny stock | Fails | price 0.77 (under $5) |
| How it ranks | Rating | From | |
|---|---|---|---|
| Value | Strong | 88% below fair value | |
| Premium | Weak | no option data | |
| Moat | Weak | moat 1.4/10 | |
| Health | Weak | Piotroski 3/9 | |
| Red Flags | Fair | not scored yet - half marks | |
| Option trading | Weak | no option volume data | |
| Stability | Fair | beta 1.13, $0M company |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls: a stock must pass all 9 Wheel Trade Filters to score 70, and the score then ranks the ones that pass; the Sunday Scan is the top 10. It is updated nightly and is not a recommendation. How the Wheel Score works · the walkthrough lesson shows how it fits into a trade, start to finish.
Upcoming events
No upcoming earnings date is recorded for PRFX in the nightly calendar.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Drug Manufacturers - Specialty & Generic
The 12 companies below are the closest to PRF Technologies Ltd. by market cap within the Drug Manufacturers - Specialty & Generic industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| SXTC China SXT Pharmaceuticals, Inc. | 2.98 | 3,539.98 | +100% | 24No options | $16K |
| IMCC IM Cannabis Corp. | 0.7168 | 1.33 | +46% | 24No options | $433K |
| UPC Universe Pharmaceuticals Inc. | 1.47 | 7,264.87 | +100% | 26No options | $929K |
| RDHL RedHill Biopharma Ltd. | 0.4220 | - | - | 8No options | $1M |
| PCYN Procyon Corporation | 0.1800 | 0.2057 | +12% | 19No options | $1M |
| AKAN Akanda Corp. | 0.9998 | - | - | 9No options | $2M |
| GELS Gelteq Limited Ordinary Shares | 0.4611 | - | - | 12No options | $4M |
| YCBD cbdMD, Inc. | 0.4060 | - | - | 8No options | $5M |
| SNOA Sonoma Pharmaceuticals, Inc. | 1.11 | - | - | 13No options | $5M |
| SBFM Sunshine Biopharma, Inc. | 2.65 | - | - | 10No options | $6M |
| CABR Caring Brands, Inc. | 0.9000 | 0.1461 | -516% | 15No options | $8M |
| INM InMed Pharmaceuticals Inc. | 1.75 | - | - | 11No options | $10M |
Scan the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the top 10 stocks that pass all 9 Wheel Trade Filters, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about PRFX
Is PRFX undervalued right now?
By the GLS models, yes: at 0.7650 the stock is 88% below the average fair value of 6.39 (data as of 5 Nov 2026). Whether the discount is deserved is the question to research next.
What is the Wheel Score of PRFX and what does it mean?
PRFX has no listed options in our nightly snapshot, so it cannot be wheeled; it fails the first Wheel Trade Filter (options that actually trade), stays under 70 and is shown as "No options".
What is the GLS fair value for PRFX?
6.39 per share as of 5 Nov 2026 - the simple average of the 1 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does PRF Technologies Ltd. report earnings next?
No upcoming earnings date is recorded for PRFX in our calendar as of 5 Nov 2026; the Calendars page is refreshed every morning.
Does PRFX have listed options, and how liquid are they?
No. The nightly options snapshot found no listed contracts on PRFX, so the wheel strategy cannot be run on it and the Wheel Score stays under 70.